非小细胞肺癌中SLC22A18的表达及其临床意义

背景与目的已有的研究证明:多药耐药(multidrug resistance,MDR)是肺癌化疗失败的主要原因,研究MDR的产生机制对于提高肺癌的化疗疗效有着重要的临床意义。SLC22A18基因编码蛋白与跨膜转运体相似,影响药物敏感性、细胞代谢和生长,可能在肺癌MDR的产生中发挥一定作用。本研究旨在检测SLC22A18在非小细胞肺癌(non-small cell lung cancer,NSCLC)及相应正常组织中的表达,并分析其与组织学类型、分级和TNM分期的关系。方法应用免疫组化EnVinsion法检测SLC22A18在96例NSCLC及正常组织中的表达,结果用统计学软件SPSS17.0进...

Full description

Saved in:
Bibliographic Details
Published in中国肺癌杂志 Vol. 15; no. 1; pp. 17 - 20
Main Author 雷鸣 程庆书 赵亚超 刘涛 王雪娇 邓迎春 杨菁 张志培
Format Journal Article
LanguageChinese
Published 第四军医大学唐都医院胸外科,西安,710038 2012
Subjects
Online AccessGet full text
ISSN1009-3419
1999-6187
DOI10.3779/j.issn.1009-3419.2012.01.04

Cover

Abstract 背景与目的已有的研究证明:多药耐药(multidrug resistance,MDR)是肺癌化疗失败的主要原因,研究MDR的产生机制对于提高肺癌的化疗疗效有着重要的临床意义。SLC22A18基因编码蛋白与跨膜转运体相似,影响药物敏感性、细胞代谢和生长,可能在肺癌MDR的产生中发挥一定作用。本研究旨在检测SLC22A18在非小细胞肺癌(non-small cell lung cancer,NSCLC)及相应正常组织中的表达,并分析其与组织学类型、分级和TNM分期的关系。方法应用免疫组化EnVinsion法检测SLC22A18在96例NSCLC及正常组织中的表达,结果用统计学软件SPSS17.0进行分析。结果 SLC22A18主要定位于胞膜和胞质中。SLC22A18在NSCLC中的表达高于正常组织,差异明显(P〈0.01),鳞癌、腺癌阳性率分别为68.0%和78.2%,差异性有统计学意义(P〈0.05)。鳞癌、腺癌不同病理分级、TNM分期间SLC22A18表达差异性均有统计学意义,癌组织分化越差、分期越晚,SLC22A18表达越高(P〈0.05)。结论 SLC22A18在NSCLC组织中高表达,表达的高低与组织学类型、分级、TNM分期有关,本研究为进一步探讨SLC22A18在肿瘤中的表达及可能的耐药作用提供了实验依据。
AbstractList R734.2; 背景与目的 已有的研究证明:多药耐药( multidrug resistance,MDR)是肺癌化疗失败的主要原因,研究MDR的产生机制对于提高肺癌的化疗疗效有着重要的临床意义.SLC22A18基因编码蛋白与跨膜转运体相似,影响药物敏感性、细胞代谢和生长,可能在肺癌MDR的产生中发挥一定作用.本研究旨在检测SLC22A18在非小细胞肺癌( non-small cell lung cancer,NSCLC)及相应正常组织中的表达,并分析其与组织学类型、分级和TNM分期的关系.方法 应用免疫组化EnVinsion法检测SLC22A18在96例NSCLC及正常组织中的表达,结果用统计学软件SPSS 17.0进行分析.结果 SLC22A18主要定位于胞膜和胞质中.SLC22A18在NSCLC中的表达高于正常组织,差异明显(P<0.01),鳞癌、腺癌阳性率分别为68.0%和78.2%,差异性有统计学意义(P<0.05).鳞癌、腺癌不同病理分级、TNM分期间SLC22A18表达差异性均有统计学意义,癌组织分化越差、分期越晚,SLC22A18表达越高(P<0.05).结论 SLC22A18在NSCLC组织中高表达,表达的高低与组织学类型、分级、TNM分期有关,本研究为进一步探讨SLC22A18在肿瘤中的表达及可能的耐药作用提供了实验依据.
背景与目的已有的研究证明:多药耐药(multidrug resistance,MDR)是肺癌化疗失败的主要原因,研究MDR的产生机制对于提高肺癌的化疗疗效有着重要的临床意义。SLC22A18基因编码蛋白与跨膜转运体相似,影响药物敏感性、细胞代谢和生长,可能在肺癌MDR的产生中发挥一定作用。本研究旨在检测SLC22A18在非小细胞肺癌(non-small cell lung cancer,NSCLC)及相应正常组织中的表达,并分析其与组织学类型、分级和TNM分期的关系。方法应用免疫组化EnVinsion法检测SLC22A18在96例NSCLC及正常组织中的表达,结果用统计学软件SPSS17.0进行分析。结果 SLC22A18主要定位于胞膜和胞质中。SLC22A18在NSCLC中的表达高于正常组织,差异明显(P〈0.01),鳞癌、腺癌阳性率分别为68.0%和78.2%,差异性有统计学意义(P〈0.05)。鳞癌、腺癌不同病理分级、TNM分期间SLC22A18表达差异性均有统计学意义,癌组织分化越差、分期越晚,SLC22A18表达越高(P〈0.05)。结论 SLC22A18在NSCLC组织中高表达,表达的高低与组织学类型、分级、TNM分期有关,本研究为进一步探讨SLC22A18在肿瘤中的表达及可能的耐药作用提供了实验依据。
Author 雷鸣 程庆书 赵亚超 刘涛 王雪娇 邓迎春 杨菁 张志培
AuthorAffiliation 第四军医大学唐都医院胸外科,西安710038
AuthorAffiliation_xml – name: 第四军医大学唐都医院胸外科,西安,710038
Author_FL JingYANG
Tao LIU
Zhipei ZHANG
Qingshu CHENG
Ming LEI
Xuejiao WANG
Yingchun DENG
Yachao ZHAC
Author_FL_xml – sequence: 1
  fullname: Ming LEI
– sequence: 2
  fullname: Qingshu CHENG
– sequence: 3
  fullname: Yachao ZHAC
– sequence: 4
  fullname: Tao LIU
– sequence: 5
  fullname: Xuejiao WANG
– sequence: 6
  fullname: Yingchun DENG
– sequence: 7
  fullname: JingYANG
– sequence: 8
  fullname: Zhipei ZHANG
Author_xml – sequence: 1
  fullname: 雷鸣 程庆书 赵亚超 刘涛 王雪娇 邓迎春 杨菁 张志培
BookMark eNo1j01LAlEYhS9hkFo_Ilq0mum93_cuRfoCoUXuZbx3xpS6lkNELsuCJHBdkNCuTdAiwgz8NU5O_6IRa3XO4uE8nALKubYLEdrA4FMp9VbLb8ax8zGA9ijD2ieAiQ_YB7aE8lhr7QmsZC7r_8gKKsRxC0AQTVkeqZ-nYfI2mH3dptfD9Go8e7ifjl4PK2VCSljNHnvp80s6mSSDfnLzMR29J-P-d28w_bxbRctRcByHa39ZRNWd7Wp5z6sc7O6XSxXPcMU8g-tgAXgE1gCTobKSMmYsDgkX1DBliKgba7k0SgBYAZgJLHhIKAAoRotoczF7EbgocI1aq33ecZmw1m1EQbc7PwzZuTm5viDNUds1zpoZe9ppngSdyxoDzmXmo78sYmer
ClassificationCodes R734.2
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3779/j.issn.1009-3419.2012.01.04
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Expression and Its Clinical Significance of SLC22A18 in Non-small Cell Lung Cancer
DocumentTitle_FL Expression and Its Clinical Significance of SLC22A18 in Non-small Cell Lung Cancer
EISSN 1999-6187
EndPage 20
ExternalDocumentID zgfazz201201004
40557563
GroupedDBID ---
-05
04C
29R
2B.
2C~
2RA
2WC
3V.
5GY
5VS
6PF
92F
92I
92L
AAWTL
ABUWG
ACGFS
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVBZV
C1A
CCEZO
CCPQU
CIEJG
CQIGP
CW9
DIK
E3Z
EBD
EIHBH
EMOBN
EOJEC
F5P
GROUPED_DOAJ
HYE
IPNFZ
KQ8
KWQ
OBODZ
OK1
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TCJ
TGQ
U1G
U5O
W91
~WA
4A8
93N
PGMZT
PHGZM
PHGZT
PMFND
PSX
ID FETCH-LOGICAL-c584-c1b0d005f0dc047e8d7344cd1e2563c48c26bcdd57c8600d60146165e23000843
ISSN 1009-3419
IngestDate Thu May 29 03:56:17 EDT 2025
Wed Feb 14 10:32:24 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords 肺肿瘤
免疫组织化学
SLC22A18
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c584-c1b0d005f0dc047e8d7344cd1e2563c48c26bcdd57c8600d60146165e23000843
Notes Lung neoplasms; SLC22A18; Immun ohistochemistry
Ming LEI, Qingshu CHENG, Yachao ZHAO, Tao LIU, Xuejiao WANG, Yingchun DENG, Jing YANG, Zhipei ZHANG Department of oracic Surgery, Tangdu Hospital, the Fourth Military Medical University, Xi'an 710038, China
12-1395/R
Background and objective It has been proven that multidrug resistance (MDR) is the main cause of chemotherapy failure in lung cancer. Research on emergence mechanisms of MDR has great clinical signi cance in improving the curative e ciency of lung cancer chemotherapy. Proteins encoded by the SLC22A18 gene, which is similar to the transmembrane transporter, may in uence the sensitivity of chemotherapeutics as well as the metabolism and growth of cells. In addition, these proteins probably have some e ect on the development of lung cancer MDR. e aim of the present study is to investigate the expression of SLC22A18 protein in non-small cell lung cancer (NSCLC) as well as in corresponding normal lung tissue. Furthermore, the relationship between SLC22A18 e
PageCount 4
ParticipantIDs wanfang_journals_zgfazz201201004
chongqing_primary_40557563
PublicationCentury 2000
PublicationDate 2012
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – year: 2012
  text: 2012
PublicationDecade 2010
PublicationTitle 中国肺癌杂志
PublicationTitleAlternate Chinese Journal of Lung Cancer
PublicationTitle_FL Chinese Journal of Lung Cancer
PublicationYear 2012
Publisher 第四军医大学唐都医院胸外科,西安,710038
Publisher_xml – name: 第四军医大学唐都医院胸外科,西安,710038
SSID ssj0062934
ssib002262905
ssib044765436
ssib001103766
ssib038074678
ssib051369142
Score 1.8934648
Snippet 背景与目的已有的研究证明:多药耐药(multidrug...
R734.2; 背景与目的 已有的研究证明:多药耐药( multidrug...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 17
SubjectTerms SLC22A18
免疫组织化学
肺肿瘤
Title 非小细胞肺癌中SLC22A18的表达及其临床意义
URI http://lib.cqvip.com/qk/91098A/201201/40557563.html
https://d.wanfangdata.com.cn/periodical/zgfazz201201004
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1NaxNBdKgpFC_iJ7ZqCegcU7O7s7Mzx5lkQxFbRCP0FrJf7UFSP9JLjloFi5CzggVvXgQPIrVCf01i4r_wvdnN7mqLX7Asj3lv3se87L43k5m3hNzgYQBROXRqYYyrVVbEahLm2DUsQumygCdxgoeT19b56n12a8PdmDv1oLRraacfrISDE8-V_I9XoQ38iqdk_8GzOVNoABj8C3fwMNz_ysfUl1Q2qfSp71Jdp6JFfY9qTQWnvqDCMSgAbKoVoqSkokF9RrWgqnnvdsO2lSUMRlHBkFZZVAkEtI8XMAauQhkAhPCst2ZGpjIojn1ROKBAgixnvLk0pJea6uZJGnG0AxqRZ4vKPDgaC6GThwCycQqMh4oKPdODZ-IVL0hATxcvxCi0EVtAW7cgAbMElQJVAIzU5WUQq5guG3ENvFIzpJEr-Axo4LADoBhVngGaoIkhZlTWUX1wh26WiCUar-zMU2Bc2l1yIwuGBoJMw7jEDApifRhcaMRaSU45nuB_T1gy76eA4x57sNLokZ5izfIQc0bwWITD-pAmwiH7lZw97lG0Tf1ZVgT2fLvlYDPpDgZIUrdM8dx52_Mst0Lmtb9-526RPuOh0fJ03ua2LOIBfpsA4mr-vmbMw5PJOb1rOVxaLC_fBp3TXR0zLRfI9cyEm78xAKucbG33Nh9B7maO0vWSbm-zlPW1z5Iz2XStqtJn7xyZG2ydJwtr2YaUC0R8f7s__jicfH0xfbY_fXo4ef1qdPBh9mBN3uxO372fHh2Nh3vj559HB5_Gh3vfdoejLy8vknbLbzdWa9nHSGoh5Oi10ArqEUSspB6FdebFIvIcxsLIimHO4IRMhDYPwihyvVDAHCLiWJTJ4m4MU3z8ZoVziVR62734MqkmEkcaXpFBBCycqBvzLiTpPIjdpBtE8SJZyu3vPExrznQY1soDSYukmg1IJ3sRPen84t6lP5NcIacRTpcSr5JK__FOfA2S636wnP0mls3i1A9rLZmU
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%9D%9E%E5%B0%8F%E7%BB%86%E8%83%9E%E8%82%BA%E7%99%8C%E4%B8%ADSLC22A18%E7%9A%84%E8%A1%A8%E8%BE%BE%E5%8F%8A%E5%85%B6%E4%B8%B4%E5%BA%8A%E6%84%8F%E4%B9%89&rft.jtitle=%E4%B8%AD%E5%9B%BD%E8%82%BA%E7%99%8C%E6%9D%82%E5%BF%97&rft.au=%E9%9B%B7%E9%B8%A3&rft.au=%E7%A8%8B%E5%BA%86%E4%B9%A6&rft.au=%E8%B5%B5%E4%BA%9A%E8%B6%85&rft.au=%E5%88%98%E6%B6%9B&rft.date=2012&rft.pub=%E7%AC%AC%E5%9B%9B%E5%86%9B%E5%8C%BB%E5%A4%A7%E5%AD%A6%E5%94%90%E9%83%BD%E5%8C%BB%E9%99%A2%E8%83%B8%E5%A4%96%E7%A7%91%2C%E8%A5%BF%E5%AE%89%2C710038&rft.issn=1009-3419&rft.volume=15&rft.issue=1&rft.spage=17&rft.epage=20&rft_id=info:doi/10.3779%2Fj.issn.1009-3419.2012.01.04&rft.externalDocID=zgfazz201201004
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F91098A%2F91098A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgfazz%2Fzgfazz.jpg